SCHEMBL2027461

SCHEMBL2027461

CCCCCCCC#Cc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.58
FFAR4 Q5NUL3 1/20 0.58
MMP2 P08253 1/20 0.56
MMP12 P39900 1/20 0.56
KCNH2 Q12809 1/20 0.56
NPSR1 Q6W5P4 1/20 0.47
CYP3A4 P08684 3/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
THPO P40225 1/20 0.47
BLM P54132 1/20 0.45
PMP22 Q01453 1/20 0.45
CYSLTR2 Q9NS75 1/20 0.45
CYSLTR1 Q9Y271 1/20 0.45
HTR2A P28223 1/20 0.44
GGPS1 O95749 1/20 0.44
TSHR P16473 2/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4071200 1.00 FFAR1 (0.58) FFAR1FFAR4MMP2MMP12KCNH2
SCHEMBL7139040 1.00 FFAR1 (0.58) FFAR1FFAR4MMP2MMP12KCNH2
SCHEMBL2350387 1.00 FFAR1 (0.58) FFAR1FFAR4MMP2MMP12KCNH2
SCHEMBL4073903 1.00 FFAR1 (0.58) FFAR1FFAR4MMP2MMP12KCNH2
SCHEMBL9015870 1.00 FFAR1 (0.58) FFAR1FFAR4MMP2MMP12KCNH2
SCHEMBL5314931 0.98 FFAR1 (0.55) FFAR1FFAR4MMP2MMP12KCNH2
SCHEMBL614578 0.92 CYP1A2 (0.50) FFAR1FFAR4MMP2MMP12KCNH2
Hydrochloric Acid SCHEMBL31144511 0.90 BLM (0.52) FFAR1FFAR4MMP2MMP12KCNH2
SCHEMBL5886652 0.90 FFAR1 (0.63) FFAR1FFAR4MMP2MMP12KCNH2
SCHEMBL5089564 0.88 NPSR1 (0.47) FFAR1FFAR4MMP2MMP12KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110214200-B Cobalt agglomeration resistance and gap filling performance enhanced by doping ruthenium 应用材料公司 2021-12-10 CN disclosed
CN-107078036-B Method for thermally forming selective cobalt layer 应用材料公司 2021-03-30 CN disclosed
EP-2046705-B1 NOVEL POLYMERS BASF SE (DE) 2015-09-16 EP disclosed
EP-2514736-A1 Intermediates for Polymers BASF SE (DE) 2012-10-24 EP disclosed
US-7968872-B2 Polymers BASF SE (DE) 2011-06-28 US disclosed
US-20090203866-A1 Novel Polymers BASF SE (DE) 2009-08-13 US disclosed
EP-2046705-A1 NOVEL POLYMERS Ciba Holding Inc. (CH) 2009-04-15 EP disclosed
WO-2008012250-A1 NOVEL POLYMERS CIBA HOLDING INC. (CH) 2008-01-31 WO disclosed
EP-0748823-A1 Catalyst composition and process for the production of olefinic polymers NIPPON OIL CO. LTD. (JP) 1996-12-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203866-A1 Novel Polymers PLEC, PUF60, VIM FFAR1 3784/4885FFAR4 4160/4885MMP2 3334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.